Medtronic plc (MDT) › Cash & EquivalentsMedtronic plc (MDT) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2012: $1.17B2013: $919.00M2014: $1.40B2015: $4.84B2016: $2.88B2017: $4.97B2018: $3.67B2019: $4.39B2020: $4.14B2021: $3.59B2022: $3.71B2023: $1.54B2024: $1.28B2025: $2.22B$2.22B2012Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$2.22B+72.7%2024$1.28B-16.8%2023$1.54B-58.5%2022$3.71B+3.4%2021$3.59B-13.2%2020$4.14B-5.8%2019$4.39B+19.7%2018$3.67B-26.1%2017$4.97B+72.7%2016$2.88B-40.6%2015$4.84B+245.2%2014$1.40B+52.7%2013$919.00M-21.6%2012$1.17B—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share